“He really feels happiness here,” Chris Liu, Yang’s interpreter, said after relaying Yang questions from The Associated Press. “And then, he’s really willing to compete with everyone and ...

Full Year Core Diluted Earnings Guidance: $3.05 to $3.15 per share. Alcon Inc (NYSE:ALC) reported sales of $2.5 billion for the first quarter, reflecting a 3% growth, showcasing the company's ...

Alcon (NYSE:ALC) shares fell 9% in premarket trading on Wednesday, after the Swiss-American pharmaceutical and medical device company missed estimates for quarterly earnings. The company also ...

Alcon Inc. (NYSE:ALC) is scheduled to announce Q1 earnings results on Wednesday, May 14th, before market open. The consensus EPS Estimate is $0.77 (-1.3% Y/Y) and the consensus Revenue Estimate is ...

GENEVA, May 06, 2025--(BUSINESS WIRE)--Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed ...

Yang tells PEOPLE the show's 50th anniversary special gave him a glimpse of "what life after the show is like and how beautiful it is" for former cast members Erin Clack is a Staff Editor for ...

Yang Kum-pi and Liu Wan-yu on Thursday teamed up at the ISSF World Cup Rifle/Pistol/Shotgun in Buenos Aires to win the gold medal in the trap mixed team event. Yang and Liu were tied with Australia’s ...

Alcon, a leader in eye care, has shown solid performance since its 2019 spin-off, with strong growth prospects and strategic acquisitions enhancing its long-term outlook. The company reported ...

11,20 "I was excited to learn that Alcon evolved this leading technology for more light utilization and less light scatter. 1,2,* My early patient results with PanOptix Pro support that this ...

Editor’s note: This is a developing news story. Please check back soon for updates. Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as ...

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a majority stake in the clinical-stage company and replacing its CEO.

GENEVA, March 26, 2025--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a ...